Principal Scientist, Oncology Research jobs in United States
cer-icon
Apply on Employer Site
company-logo

Gilead Sciences · 3 days ago

Principal Scientist, Oncology Research

Gilead Sciences is dedicated to creating a healthier world for all people by tackling significant diseases. The Principal Scientist of Tumor-Intrinsic Biology will lead a discovery lab, mentor a scientific team, and collaborate across various functions to develop innovative therapies that impact patients' lives.

BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Mentor a lab-based scientific team, advancing their projects and careers
Serve as a scientific and technical thought leader throughout the Research organization
Collaborate across functions to guide interdisciplinary projects, with experts in oncology, immune-oncology, protein engineering, chemistry, translational medicine, biomarkers and clinical development. Identify project risks and mitigate effectively, while communicating with project teams and other leaders
Proactively ideate to accelerate early-stage discovery activities, enhance understanding of disease mechanisms, and develop new technologies and novel targeting modalities
Develop expertise in relevant scientific fields and the external landscape, including the scientific literature, conference proceedings, and competitive programs. As an in-house expert, propose creative and rigorous research to discover, validate and understand targets
Think critically and creatively, emphasizing nimble decision making that balances risk-taking with thoughtful experimentation within the strategic/competitive context to fuel a differentiated pre-clinical pipeline
Contribute expertise to multi-disciplinary due diligence teams to evaluate and recommend partnerships and acquisitions
Contribute to research reports, INDs, and patent filings
Establish an external presence through peer-reviewed publications, conference presentations, and external collaborations

Qualification

Ph.D. in relevant fieldTumor biology expertiseCancer genomics knowledgeDrug discovery experienceResearch report contributionsTeam leadershipTechnical thought leadershipCommunicationInterpersonal skills

Required

Ph.D. degree and 5+ years of experience (tumor biology, drug discovery, target identification and technology development), with post-doctoral training highly preferred
Strong track record of impact in scientific field, including first- or senior-author publications in peer-reviewed journals and conference presentations
Strong knowledge base in cancer genomics and oncogenic signaling
Broad technical skillset of cutting-edge methods and models of cancer, in vitro and in vivo, with experience in biochemically analyzing protein (and protein-nucleic acid) complexes a plus
Demonstrated success in leading research teams to productive, creative, data-driven decisions
Team-centric mindset, with proven managerial excellence and ability to motivate skilled team members from diverse backgrounds
Excellent communication and interpersonal skills

Benefits

Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans

Company

Gilead Sciences

company-logo
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

H1B Sponsorship

Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)

Funding

Current Stage
Public Company
Total Funding
$4.41B
Key Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B

Leadership Team

leader-logo
Keeley Wettan
Senior Vice President, Legal
linkedin
leader-logo
Patrick Loerch
Senior Vice President, Clinical Data Science
linkedin
Company data provided by crunchbase